The excitatory neurotransmitter acetylcholine (ACh) not only controls muscle cell contraction, but can also lead to a change in muscle cell physiology. For example, in mammals, chronic exposure to the ACh agonist nicotine can desensitize cells, leading to addiction. To better understand how a post-synaptic cell responds to ACh, we are examining the genome-wide transcriptional changes in C. elegans striated muscle cells in response to varying cholinergic signal. To do this, we first needed to develop a method to measure relative gene expression levels in single tissues in C. elegans. Previous DNA microarray experiments have compared gene expression levels from entire worms rather than from specific tissues. A major limitation to this approach is that gene expression changes in one tissue, such as muscle, could be obscured by expression in other tissues. To isolate muscle mRNAs, we use the
myo-3 promoter (a gift from A. Fire) to drive expression of an epitope-tagged poly(A)-mRNA-binding protein in striated muscle. The mRNA/tagged-protein complex is co-immunoprecipitated from whole-animal lysates using antibodies against the epitope tag. mRNAs significantly enriched in muscle are identified by comparing the immunoprecipitated mRNA to the mRNA present in the initial worm extract using DNA microarrays. We call this technique "mRNA-tagging". L1-muscle mRNA-tagging (6 repeats) revealed 1453 genes that were significantly enriched, including most characterized muscle-specific genes (positive controls) and excluding most non-muscle genes (negative controls). We repeated the entire experiment using L2 larvae (6 repeats) and found that there were few significant differences between L1 and L2 muscle. Together, these results indicate that mRNA-tagging successfully identifies genes expressed in striated muscle. To profile transcriptional changes in striated muscle in response to ACh, we either excited muscle cells using the nicotinic ACh agonist levamisole or prevented normal muscle contraction using an ACh receptor mutant. We then used mRNA tagging to identify genes expressed in excited and mutant muscle, and compared those genes to each other and to those expressed in "normal" muscle. 304 genes show increased expression and 851 genes show decreased expression in levamisole-excited muscle, relative to normal or mutant muscle. The gene expression data indicates that ACh excitation decreases the relative expression of ACh receptors and other ligand-gated ion channels, which may represent new ACh receptor candidates. Specifically, the expression levels of seven ligand-gated receptors, two 2nd messenger-gated receptors, and two characterized ACh receptor genes (
lev-1 and
unc-29), were significantly lower in the levamisole-treated or normal worms than they were in the mutant. The overall effect may be to desensitize cells to acetylcholine following strong activation, and to sensitize cells in ACh receptor mutants.